Differentiated reactivity of whole blood neonatal platelets to various agonists.
Neonatal platelets have been occasionally reported to show a reduced response to various agonists. The molecular mechanism(s) of such a depressed reactivity remains unclear. To further address this problem we studied neonatal platelet activation with thrombin, TRAP (thrombin receptor activating peptide, Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe) and ADP in 42 healthy 1-2 day old neonates using a whole peripheral blood flow cytometry. The neonates did not show an increased fraction of P-selectin-positive circulating platelets, whereas the expression of GPIb (glycoprotein Ib) in resting neonatal platelets was significantly lower compared to adults. Neonatal platelets were significantly less reactive than adult platelets to thrombin and TRAP, especially at lower agonist concentrations, but not to ADP or when incubated for 1 h at room temperature. Activation of neonatal platelets with agonists resulted in a marked alterations in the expression of P-selectin, whereas the internalization of GPIb was not affected. The reduced neonatal platelet sensitivity to thrombin and TRAP was accompanied by significantly reduced ATIII (antithrombin III) and increased prothrombin fragment F(1+2) in neonatal plasma. We conclude that various receptor systems potentially able to bind thrombin are relatively insensitive in neonatal platelets. The novelty of our work is that neonatal platelet hyposensitivity is not a generalized phenomenon, but concerns only selected agonists and selected receptor systems.
Pietrucha
T
T
Department of Biochemistry, Medical University of Lódź, Poland.
Wojciechowski
T
T
Greger
J
J
J drzejewska
E
E
Nowak
S
S
Chrul
S
S
Golański
J
J
Watala
C
C
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D000367:Age Factors; D000990:Antithrombin III / Q000032:analysis; D001792:Blood Platelets / Q000737:chemistry / Q000187:drug effects*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007231:Infant, Newborn / Q000097:blood*; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000032:analysis; D010446:Peptide Fragments / Q000032:analysis; D010447:Peptide Hydrolases / Q000032:analysis; D015539:Platelet Activation / Q000187:drug effects*; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000032:analysis; D011506:Proteins / Q000494:pharmacology; D011516:Prothrombin / Q000032:analysis; D044463:Receptor, PAR-1; D018179:Receptors, Thrombin / Q000819:agonists*; D013917:Thrombin / Q000494:pharmacology
D019007:P-Selectin; D010446:Peptide Fragments; D019038:Platelet Glycoprotein GPIb-IX Complex; D011506:Proteins; D044463:Receptor, PAR-1; D018179:Receptors, Thrombin; C046193:antithrombin III-protease complex; C045879:prothrombin fragment 1.2; D000244:Adenosine Diphosphate; D000990:Antithrombin III; D011516:Prothrombin; D010447:Peptide Hydrolases; D013917:Thrombin